Cavendish Impact Capital

Massive Bio, Inc., established in 2014, specializes in connecting cancer patients with clinical trials through its AI-powered platform. The company offers patient identification, pre-screening, and enrollment assistance, primarily targeting community practices. Massive Bio's services aim to streamline drug development for pharmaceutical companies by providing access to relevant patient data while addressing 'last mile' issues such as site and financial considerations of patients. The company caters to cancer patients, oncologists, payers, and insurance companies, operating two platforms: a B2C platform offering on-demand products and services for patients and primary oncologists, and a B2B platform designed for hospitals and insurance companies. Massive Bio's headquarters are in New York City, with an additional office in Newtown, Pennsylvania.

Sandstone Diagnostics, Inc. is a technology and healthcare company based in Pleasanton, California, that specializes in developing medical products and research tools focused on male fertility management. Founded in 2012, the company manufactures innovative devices such as the Torq ZDrive, which separates blood cells from liquid plasma at the point of collection, and the Torq Microvolume Rotor, a tool for remote blood sampling that facilitates comprehensive diagnostic testing. Additionally, Sandstone offers the Trak fertility system, which includes an engine, a disposable test plate, a sample collection cup, and a dropper, enabling men to monitor their sperm quality and take proactive steps toward improving their fertility. The accompanying Trak mobile application allows users to track their fertility data over time, identify potential fertility issues, and enhance their chances of conception. Sandstone Diagnostics aims to empower couples to manage their reproductive health in the comfort and privacy of their homes.

Sandstone Diagnostics is a Bay Area biotech company developing instruments and consumables for point-of-care medical testing. Sandstone’s lead product, Trak, is a consumer semen analysis platform that provides a simple and accurate way to monitor sperm quality from the comfort of home. Trak is a tool for men to take charge of their fertility, boost their sperm quality, and improve their chances of conception. Sandstone was co-founded in 2012 by Ph.D. scientists developing medical technologies for national defense applications at Sandia National Laboratories.

Turner Imaging Systems, Inc. is a company based in Orem, Utah, that specializes in the development, manufacturing, and marketing of innovative x-ray imaging systems. Founded in 2016, the company has created the Smart-C Mini-C Arm, a battery-powered, portable fluoroscopy and x-ray imaging device designed for ease of use in various settings. This fully-functional mini-C-arm system allows users to acquire x-ray images conveniently and efficiently, enhancing the delivery of fluoroscopy services. Turner Imaging Systems aims to expand access to x-ray imaging, particularly in under-served areas and humanitarian efforts globally, thereby improving healthcare delivery in diverse environments.

Turner Imaging Systems, Inc. is a company based in Orem, Utah, that specializes in the development, manufacturing, and marketing of innovative x-ray imaging systems. Founded in 2016, the company has created the Smart-C Mini-C Arm, a battery-powered, portable fluoroscopy and x-ray imaging device designed for ease of use in various settings. This fully-functional mini-C-arm system allows users to acquire x-ray images conveniently and efficiently, enhancing the delivery of fluoroscopy services. Turner Imaging Systems aims to expand access to x-ray imaging, particularly in under-served areas and humanitarian efforts globally, thereby improving healthcare delivery in diverse environments.

Molecular Assemblies, Inc. is a San Diego-based company that specializes in enzymatic DNA synthesis technology, aimed at creating DNA-based products across various industries. Founded in 2013, the company has developed a proprietary method that allows for the reliable, affordable, and sustainable production of long, high-quality, sequence-specific DNA. This innovative technology is designed to support advancements in industrial synthetic biology, personalized therapeutics, precision diagnostics, and has potential applications in information storage and nanotechnology. With a strong executive and scientific team, as well as a robust intellectual property portfolio, Molecular Assemblies is positioned to enhance the capabilities of researchers and contribute to the evolution of DNA-based applications.